Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Current Leases (2022 - 2025)

Historic Current Leases for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $591000.0.

  • Phathom Pharmaceuticals' Current Leases fell 1308.82% to $591000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $591000.0, marking a year-over-year decrease of 1308.82%. This contributed to the annual value of $501000.0 for FY2024, which is 3099.17% down from last year.
  • As of Q3 2025, Phathom Pharmaceuticals' Current Leases stood at $591000.0, which was down 1308.82% from $238000.0 recorded in Q2 2025.
  • Phathom Pharmaceuticals' Current Leases' 5-year high stood at $730000.0 during Q1 2024, with a 5-year trough of $238000.0 in Q2 2025.
  • Moreover, its 4-year median value for Current Leases was $685000.0 (2022), whereas its average is $610866.7.
  • In the last 5 years, Phathom Pharmaceuticals' Current Leases soared by 4530.61% in 2023 and then tumbled by 6694.44% in 2025.
  • Over the past 4 years, Phathom Pharmaceuticals' Current Leases (Quarter) stood at $708000.0 in 2022, then rose by 2.54% to $726000.0 in 2023, then crashed by 30.99% to $501000.0 in 2024, then rose by 17.96% to $591000.0 in 2025.
  • Its last three reported values are $591000.0 in Q3 2025, $238000.0 for Q2 2025, and $316000.0 during Q1 2025.